TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $874,000 | -91.2% | 39,577 | -87.7% | 0.01% | -88.6% |
| Q4 2020 | $9,987,000 | +52.2% | 322,903 | 0.0% | 0.08% | +58.0% |
| Q3 2020 | $6,561,000 | +32.3% | 322,903 | 0.0% | 0.05% | +11.1% |
| Q2 2020 | $4,960,000 | +98.5% | 322,903 | 0.0% | 0.04% | +32.4% |
| Q1 2020 | $2,499,000 | -45.8% | 322,903 | 0.0% | 0.03% | -40.4% |
| Q4 2019 | $4,611,000 | -5.0% | 322,903 | 0.0% | 0.06% | -14.9% |
| Q3 2019 | $4,853,000 | – | 322,903 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |